Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system

Texto completo
Autor(es):
Bahamondes, Luis [1] ; Espejo-Arce, Ximena ; Hidalgo, Maria M. ; Hidalgo-Regina, Creusa ; Teatin-Juliato, Cássia ; Petta, Carlos A.
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Médicas - Brasil
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: Human Reproduction; v. 21, n. 5, p. 1316-1319, May 2006.
Área do conhecimento: Ciências da Saúde - Medicina
Assunto(s):Densidade óssea   Anticoncepção   Levanogestrel
Resumo

There are concerns about the effect of hormonal contraceptives on bone mineral density (BMD), but there is currently no information available on the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on BMD. The objective of this study was to compare the BMD of LNG-IUS users with that of controls using the TCu380A intrauterine device (IUD). A cross-sectional study paired 53 women, aged 25-51 years, who had been using the LNG-IUS for 7 years, with 53 IUD users, according to age (±1 year) and body mass index (BMI; kg/m2) (±1). BMD was evaluated at the midshaft of the ulna and the distal radius of the nondominant forearm using double X-ray absorptiometry. RESULTS: Mean age of women was 34 years. BMI was slightly over 25 in both groups. Estradiol was normal. Mean BMD was 0.469 ± 0.008 and 0.467 ± 0.009 and 0.409 ± 0.009 and 0.411 ± 0.009 at the midshaft of the ulna and distal radius in LNG-IUS and IUD users, respectively, without significant differences. Women aged 25-51 years, using the LNG-IUS for 7 years, had a mean BMD similar to that of the control group of TCu380A IUD users. (AU)

Processo FAPESP: 03/08391-7 - Avaliação das repercussões clínicas e moleculares do uso de contraceptivos que contêm somente progestogênio
Beneficiário:Luis Guillermo Bahamondes
Modalidade de apoio: Auxílio à Pesquisa - Temático